Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D
NCT: NCT07593625 · RECRUITING
Brief Summary
Feasibility study to evaluate the safety and feasibility of Omnipod automated insulin delivery algorithms in individuals with type 1 diabetes. This study will enroll up to 80 participants to have a minimum of 48 participants to initiate the use of Omnipod. The study will include hotel and outpatient evaluation periods.
Frequently Asked Questions
What is Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D?
Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D is a clinical trial registered under NCT07593625. Current status: RECRUITING.
What is the status of NCT07593625?
The current status of NCT07593625 (Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D) is: RECRUITING.
When did Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D start?
Evaluating Glucose Control Using a Next-Generation AID Algorithm in Individuals With T1D started on 2026-05-25.
Related Devices
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.